M
Matteo Riva
Researcher at Katholieke Universiteit Leuven
Publications - 22
Citations - 458
Matteo Riva is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Immune system & Immunotherapy. The author has an hindex of 7, co-authored 20 publications receiving 322 citations. Previous affiliations of Matteo Riva include University of Milano-Bicocca & Université libre de Bruxelles.
Papers
More filters
Journal ArticleDOI
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
Carolien Koks,Abhishek D. Garg,Michael Ehrhardt,Matteo Riva,Lien Vandenberk,Louis Boon,Steven De Vleeschouwer,Patrizia Agostinis,Norbert Graf,Stefaan W. Van Gool +9 more
TL;DR: The therapeutic activity of NDV against GL261 tumors, evidenced in an orthotopic mouse model, is described for the first time, and the importance of a functional adaptive immune system in this paradigm was demonstrated in immunodeficient Rag2−/− mice and in CD8+ T cell depleted animals, where NDV slightly prolonged survival, but failed to induce long‐term cure.
Journal ArticleDOI
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.
Lien Vandenberk,Jochen Belmans,Matthias Van Woensel,Matthias Van Woensel,Matteo Riva,Matteo Riva,Stefaan Van Gool,Stefaan Van Gool +7 more
TL;DR: This work discusses the effects of three immunogenic treatment modalities and five potent inducers of immunogenic cell death on DC biology and their application in DC-based immunotherapy in preclinical as well as clinical settings.
Journal ArticleDOI
Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Thaïs Baert,Ann Vankerckhoven,Matteo Riva,Anaïs Van Hoylandt,Gitte Thirion,Gerhardt Holger,Thomas Mathivet,Thomas Mathivet,Ignace Vergote,An Coosemans +9 more
TL;DR: It is concluded that the adaptive immune system does not efficiently control tumor growth in the ID8-fLuc syngeneic ovarian cancer mouse model and a prominent role for MDSC as the driver of immunosuppression is discovered.
Journal ArticleDOI
Indocyanine Green Videoangiography in Aneurysm Surgery: Systematic Review and Meta-Analysis.
Matteo Riva,Matteo Riva,Matteo Riva,Sepideh Amin-Hanjani,Carlo Giussani,Olivier De Witte,Michael Bruneau +6 more
TL;DR: Because a proportion of mis‐clippings cannot be identified with ICG‐VA, this technique should still be considered complementary rather than a replacement to DSA during aneurysm surgery.
Journal ArticleDOI
Combining conventional therapy with immunotherapy: A risky business?
An Coosemans,Ann Vankerckhoven,Thaïs Baert,Louis Boon,H. Ruts,Matteo Riva,Sarah P. Blagden,Michel Delforge,Nicole Concin,Mansoor Raza Mirza,Jonathan A. Ledermann,A. du Bois,Ignace Vergote +12 more
TL;DR: Because of the failure of immunotherapy as single agent in a number of cancers, current clinical trials are focusing on combining immunotherapy with other therapies, with almost no preclinical data on this combination available.